Try our mobile app

General information

MD Medical Group Investments PLC is a private healthcare provider in Russia. The Company specializes in women's and children's healthcare.
  • Good financial results growth rate 24.4% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (19.2%)
  • Dividend yield for the last twelve months 6.8%
  • Free cash flow yield -6.8% (LTM)
  • Share price is 86.1% higher than minimum and 15.5% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (7.8x vs
    )
  • Fundamental value created in LTM (estimate)
  • Taking into account the impact of the key rate 14.0% on the change in financial parameters: EBITDA adjustment is -397 mln rub as NetDebt * (expected key rate - 3 years average 0.0%) / 2, expected EBITDA adjusted for key rate increases is 13 977 mln rub, expected mult is 7.9x, target mult is 6.6x, potential is -18.4%

Key Financials (Download financials)

Ticker: MDMG
Share price, RUB:  (-0.6%)1312
year average price 1340.65  


year start price 1270.80 2025-09-09

max close price 1552.10 2025-12-31

min close price 1053.30 2026-07-17

current price 1312.00 2026-09-08
Common stocks: 75 125 010
Dividend Yield:  6.8%
FCF Yield LTM: -6.8%
EV / LTM EBITDA:7.8x
EV / EBITDA annualized: 7.5x
Last revenue growth (y/y):  28.8%
Last growth of EBITDA (y/y):  20.0%
Historical revenue growth:  21.9%
Historical growth of EBITDA:  16.6%
Target EV / EBITDA (hist percentile):
Express share price potential:
Fundamental value created in LTM:
Fundamental value created in LTM:
 Mult Upside-14.0%
 FCF Creation-6.8%
 Growth+24.4%
 Growth Corr+2.6%
 
 Sum+6.2%
EV / LTM EBITDA mutiple calculation
Market Cap (m RUB): 98 564
Net Debt (m RUB): 6 529
EV (Enterprise Value): 105 093
EBITDA LTM (m RUB): 13 390
Net Income LTM (m RUB): 5 323
EV / LTM EBITDA: 7.8x
Net Debt / LTM EBITDA (if EBITDA > 0): 0.5x
Average daily trading volume for the week, RUB mln: 67
[auto extract] P / E 9.3x
[auto extract] P / E ann-d9.3x
[auto extract] P / B 2.6x
EBITDA margin ann-d 28.2%
Net income margin ann-d 21.5%

Revenue and EBITDA

Semi-Annual values (m RUB)

Change (y/y)

Cash Flow

FCF (m RUB), before FX effects elimination

Net Debt / Cash and Equivalents (m RUB)

Share price and dividends (Download history)

Share price

Payment RUB per share

Multiple and potential

EV / LTM EBITDA and 50% percentile

Potential dynamics

Daily trade volumes

Millions of RUB

P/B and P/E multipliers

P / B

P / E

Фьючерсы
Название Инструмент Дата экспирации Последняя цена За день Дневной объем млн руб Цена акции Контанго / бэквордация Annualized
Фьючерсный контракт MDMG-9.26 MDU6 2026-09-18 13178.00 -0.9% 9.1 1312 +0.4% +17.5%
Фьючерсный контракт MDMG-12.26 MDZ6 2026-12-18 13497.00 -0.3% 1.8 1312 +2.9% +10.8%
MSFO data *The values are shown in mln. The % change shows the difference from the same period last year

View as Pivot Table       Export as Pivot Table (xlsx)



Income


Q Revenue Gross profit Operating income Net income PercentProfit PercentLoss
 
2026 H1 24 809+29% 10 052+31% 5 498+18% 5 323+5% 235-44% -176-36%
2025 H2            
2025 H1 19 264+22% 7 649+21% 4 654+13% 5 064+4% 423-45% -275+105%
2024 H2 17 362+17% 7 169+13% 4 999+18% -3<-100% 298-9% -174+57%
2024 H1 15 760+23% 6 299+27% 4 120+26% 4 886>+200% 775>+200% -134+47%
2023 H2 14 778+13% 6 326+20% 4 238+20% 9<-100% 326+75% -111-9%
2023 H1 12 853+6% 4 966+10% 3 272+127% 11-99% 100-41% -92
2022 H2 13 063-1% 5 279-3% 3 527-3% 3 612+5% 186>+200% -121
2022 H1 12 159+1% 4 514-1% 1 442-52% 1 106-59% 170>+200%  
2021 H2 13 211+18% 5 438+22% 3 645+23% 3 455+21% 50-61%  
2021 H1 12 009+51% 4 550+71% 2 977+92% 2 688+83% 44-63%  
2020 H2 11 159 4 464 2 954 2 862 128  
2020 H1 7 974 2 663 1 550 1 471 121  


Balance


Implied interest rate for 2026 H1:
= (PercentLoss - PercentProfit) * (365 / periodLength) / (NetDebt - MinorityInterest)
= (176 - 235) * 2 / (6 529 - 272)

Q Total equity Total assets Net debt Implied interest rate NetDebt / LTM EBITDA
 
2026 H1 38 442+13% 63 651+35% 6 529<-100% -1.9% 0.49x
2025 H2 36 691+19% 49 589+27% 556<-100%   0.26x
2025 H1 34 066+19% 47 161+2% -173-99%   -0.02x
2024 H2 30 765-11% 38 961-6% -4 448-75%   -0.42x
2024 H1 28 726 46 415 -13 157   -1.29x
2023 H2 34 554<-100% 41 337+25% -17 687<-100%   -0.96x
2023 H1         -0.69x
2022 H2 -26 751 33 162 0   -0.46x
2022 H1     0<-100%   0.02x
2021 H2         0.26x
2021 H1 20 804 0 2 117   0.28x
2020 H2         0.55x
2020 H1         0.56x


Cashflow


Q Operating cashflow Investing cashflow Financial cashflow
 
2026 H1 7 060+17% -10 574+61% 5 394<-100%
2025 H2 8 874+44% -2 874+122% -396+132%
2025 H1 6 047+24% -6 567>+200% -2 072>+200%
2024 H2 6 179+32% -1 293-7% -171-70%
2024 H1 4 886+12% -927-52% -160+99%
2023 H2 4 689+99% -1 389>+200% -570-88%
2023 H1 4 366 -1 927>+200% -80-94%
2022 H2 2 359 -283-87% -4 655+91%
2022 H1   -565-25% -1 249-52%
2021 H2   -2 154+7% -2 439-1%
2021 H1   -758-59% -2 592>+200%
2020 H2   -2 015 -2 469
2020 H1   -1 865 -310
More information for subscribed users:
detailed calculation of
Potential and Created Value,
commodities affecting the company
📊 Фундаментальная аналитика MDMG на Frontier — мультипликаторы, финансы, дивиденды, потенциал